Wells Pharmacy Network LLC recalls ULTRA-TEST in Grapeseed Oil (CYP 90%/PROP 10%) Injectable, 200 mg/mL, 8 mL vial, Compounded by Wells Pharmacy, Ocala, FL
Recalled January 11, 2017 · FDA recall D-0334-2017 · Wells Pharmacy Network
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
714 vials
Sold at
Nationwide
Description
Lack of Assurance of Sterility
Product
ULTRA-TEST in Grapeseed Oil (CYP 90%/PROP 10%) Injectable, 200 mg/mL, 8 mL vial, Compounded by Wells Pharmacy, Ocala, FL
Manufacturer(s)
Wells Pharmacy Network LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →